FilingSEC EDGAR6-K
Alterity Therapeutics to Present at Investor Conference
· SEC accepted
StageScheduled
Filing content
Alterity Therapeutics CEO Dr. David Stamler is scheduled to present at the Canaccord Genuity Drug and Device Conference on October 12, 2026.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…